Assessing taxane-associated adverse events using the FDA adverse event reporting system database

Documenti analoghi

• Causes of drug-induced photosensitivity: an analysis using FDA adverse event reporting system database
  di: Lele Ge, et al.
  Pubblicazione: (2025-05-01)
• Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
  di: Iarikov, Dmitri, et al.
  Pubblicazione: (2015)
• Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database
  di: Meng, Long, et al.
  Pubblicazione: (2021)
• Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
  di: Zhuomiao Lin, et al.
  Pubblicazione: (2025-08-01)
• Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database
  di: Yang Rui, et al.
  Pubblicazione: (2025-08-01)